Accurate prediction of psuedo progression of glioma after chemoradiotherapy based on MR chemical exchange rate imaging

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063456

Enrollment

Unknown

Registered

2022-09-07

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Gliomas graded III and IV according to WHO; 2. Underwent glioma resection; 3. Plan to receive standard chemoradiotherapy; 4. MR imaging within 72 hours after glioma resection and follow-up for one year; 5. Aged 18-80 years.

Exclusion criteria

Exclusion criteria: 1. Complicated with cerebral infarction or cerebral hemorrhage or encephalitis; ; 2. Contraindicated by magnetic resonance examination; 3. Unable to complete any follow-up.

Design outcomes

Primary

Measure	Time frame
Quantitative parameters of chemical exchange rate imaging;	—

Countries

China

Contacts

Public ContactCheng Guanxun

Peking University Shenzhen Hospital

18903015678@189.cn+86 13925200816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026